ストックスクリーナーアプリを入手
4.11
2.38%
-0.10
前日終値:
$4.21
開ける：
$4.17
24時間の取引高:
194.79K
Relative Volume:
1.12
時価総額：
$172.10M
収益：
$52.84M
当期純損益:
$-11.11M
株価収益率:
-14.99
EPS:
-0.2742
ネットキャッシュフロー:
$-9.12M
1週間 パフォーマンス:
-11.61%
1か月 パフォーマンス:
+6.20%
6か月 パフォーマンス:
+10.78%
1年 パフォーマンス:
+140.35%
1日の値動き範囲:
$4.01
$4.24
1週間の範囲:
$4.01
$4.99
52週間の値動き範囲:
$1.5902
$5.08
Apyx Medical Corp Stock (APYX) Company Profile
Compare APYX vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APYX
Apyx Medical Corp
|
4.11 | 172.10M | 52.84M | -11.11M | -9.12M | -0.2742 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-11 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-12-16 | 開始されました | Roth Capital | Buy |
| 2025-11-14 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-11-12 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2024-10-17 | 開始されました | BTIG Research | Neutral |
| 2023-07-14 | 開始されました | Stephens | Overweight |
| 2022-05-20 | 開始されました | Lake Street | Buy |
| 2019-04-02 | 繰り返されました | Dougherty & Company | Buy |
すべてを表示
Apyx Medical Corp (APYX) 最新ニュース
Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity - Insider Monkey
Apyx Medical Corp (APYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Apyx Medical Corp (APYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Apyx Medical Corp (APYX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Apyx Medical Corp (APYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Apyx Medical Corp (APYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Apyx Medical Corp (APYX) Institutional Confidence - TradingKey
Apyx Medical Corp (APYX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apyx Medical (NASDAQ: APYX) COO nets 4,467 shares after option exercise - Stock Titan
Apyx Medical (NASDAQ: APYX) adds Executive Chairman, awards 450,000 RSUs - Stock Titan
Apyx Medical Corp (APYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Apyx Medical (NASDAQ: APYX) director receives grant of 50,000 stock options - Stock Titan
Apyx Medical (APYX) CFO awarded 132,066 stock options at $4.65 - Stock Titan
Apyx Medical (APYX) Sr. VP granted 63,392 stock options at $4.65 strike - Stock Titan
Apyx Medical (NASDAQ: APYX) director awarded 450,000 restricted stock units - Stock Titan
Apyx Medical (NASDAQ: APYX) CEO awarded 213,948 stock options - Stock Titan
Apyx Medical (NASDAQ: APYX) COO awarded stock options on 88,044 shares - Stock Titan
[Form 4] Apyx Medical Corp Insider Trading Activity - Stock Titan
Apyx Medical (NASDAQ: APYX) director receives 50,000 stock options at $4.65 strike - Stock Titan
Apyx Medical Corp. Hits New 52-Week High of $4.65 - MarketsMojo
Apyx Medical Corp. Hits New 52-Week High of $4.97, Up 198% - MarketsMojo
How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals - Yahoo Finance
Apyx Medical Shares Rise 6% as Body-Contouring Push Hits New Milestone - Bez Kabli
Real Renuvion patients hit the runway in Apyx’s Miami Swim Week show - Stock Titan
Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway - PR Newswire
APYX Q1 2026 Earnings: EPS Beats Expectations Despite Revenue UncertaintyEarnings Momentum Score - The Legal Advocate
APYX Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Surprise But Stock DeclinesROIC Trend Report - The Legal Advocate
APYX Technical Analysis | Trend, Signals & Chart Patterns | APYX MEDICAL CORP (NASDAQ:APYX) - ChartMill
New Apyx Medical (APYX) data backs Avéli and Renuvion cellulite treatment - Stock Titan
Why is DeFi Development Corp. (DFDV) Betting on Apyx - Kavout
Apyx Medical reports clinical data on cellulite treatment - Investing.com
One-session cellulite study shows visible dimple reduction, tighter skin - Stock Titan
APYX Stock Price, Quote & Chart | APYX MEDICAL CORP (NASDAQ:APYX) - ChartMill
Why Apyx Medical (APYX) Just Dropped -6.88% — What to Watch 2026-05-15Popular Market Picks - newser.com
TradingKey - TradingKey
Apyx Medical Announces Positive Clinical Outcomes for Renuvion and Launches AYON Body Contouring System in May 2026 - Minichart
Apyx Medical study shows improved satisfaction with Renuvion - Investing.com
Apyx Medical study: Renuvion with liposuction shows higher patient satisfaction, lower revision and abdominoplasty rates - TradingView
Apyx Medical (NASDAQ: APYX) study shows Renuvion boosts liposuction satisfaction - Stock Titan
New 113-patient study links Renuvion lipo to fewer repeat surgeries - Stock Titan
Apyx Medical receives FDA clearance for power liposuction feature By Investing.com - Investing.com South Africa
Apyx Medical Corporation Files Form 8-K Reporting Company Information and SEC Compliance Details - Minichart
Apyx Medical receives FDA clearance for power liposuction feature - Investing.com
Apyx Medical receives FDA 510(k) expansion for AYON to add power liposuction - TradingView
[8-K] Apyx Medical Corp Reports Material Event - Stock Titan
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System - ChartMill
Apyx Medical Corporation (NASDAQ:APYX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.50 - Yahoo Finance
Apyx Medical Corporation (NASDAQ:APYX) Q1 2026 Earnings Call Transcript - Insider Monkey
Apyx Medical Corp 2026 Q1 Financial Results: Key Highlights, Net Loss, and Business Developments - Minichart
Apyx raises 2026 revenue outlook to $59M-$60M as AYON demand ramps - MSN
Apyx Medical (NASDAQ: APYX) grows Q1 2026 sales 32%, narrows loss - Stock Titan
Apyx Medical Corp (APYX) 財務データ
収益
当期純利益
現金流量
EPS
Apyx Medical Corp (APYX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| CITRONOWICZ MOSHE | Senior Vice President |
Mar 15 '26 |
Option Exercise |
1.80 |
37,000 |
66,600 |
493,504 |
| Roman Shawn David | Chief Operating Officer |
Jan 27 '26 |
Option Exercise |
1.80 |
12,000 |
21,600 |
12,000 |
0.93%
大文字化:
|
ボリューム (24 時間):